Pharmacy News Article

Jul 30, 2010 (Datamonitor via COMTEX) Boston Scientific, a medical device company, has received FDA approval for two spinal cord stimulation, or SCS, leads for use with its Precision Plus SCS system, a rechargeable SCS device for the management of chronic pain of the trunk and/or limbs.

According to the company, the Linear 3-4 and Linear 3-6 percutaneous leads offer wider contact spacing to expand the lead choices available to physicians. The company plans to launch the products in the US; they were launched in Europe and other international markets earlier in 2010.

Michael Onuscheck, senior vice president and president of neuromodulation division at Boston Scientific, said: "Our products are designed to meet the unique clinical demands of SCS pain patients. The approval of these products expands our portfolio of leads for the Precision Plus System, offering pain management physicians more choices to help optimize pain relief for their patients."

http://www.datamonitor.com

Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall
not be liable for errors or delays in the content, or for any actions
taken in reliance thereon